Edition:
United Kingdom

Shanghai Pharmaceuticals Holding Co Ltd (601607.SS)

601607.SS on Shanghai Stock Exchange

24.05CNY
15 Dec 2017
Change (% chg)

¥-0.35 (-1.43%)
Prev Close
¥24.40
Open
¥24.38
Day's High
¥24.38
Day's Low
¥23.96
Volume
8,380,792
Avg. Vol
14,238,144
52-wk High
¥29.25
52-wk Low
¥18.91

Chart for

About

Shanghai Pharmaceuticals Holding Co., Ltd. is a China-based company principally engaged in the manufacture and sales of pharmaceuticals. The Company's businesses include the research and registration, production, sales, distribution and retailing of pharmaceutical products, among others. Its products are applied in cardiovascula... (more)

Overall

Beta: 0.95
Market Cap(Mil.): ¥58,598.07
Shares Outstanding(Mil.): 2,688.91
Dividend: 0.36
Yield (%): 1.52

Financials

  Industry Sector
P/E (TTM): -- 21.41 16.44
EPS (TTM): -- -- --
ROI: -- 11.88 10.62
ROE: -- 13.57 14.20

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

* Says its wholly owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration

11 Dec 2017

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

* Says its Shanghai-based unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration

05 Dec 2017

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

* Says its wholly owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration

03 Dec 2017

BRIEF-Shanghai Pharmaceuticals Holding unit to take out loan of $100 mln

* Says co's Hong Kong-based wholly owned unit will take out loan of $100 million (about 664 million yuan) form co's controlling shareholder, with term of 180 days

16 Nov 2017

Shanghai Pharma buys U.S. Cardinal Health's China business for $557 million

Shanghai Pharmaceuticals Holding Co has agreed to buy Cardinal Health Inc's China drug distribution business for $557 million, winning a highly competitive auction in a move that will greatly expand its presence nationwide.

15 Nov 2017

UPDATE 3-Shanghai Pharma buys U.S. Cardinal Health's China business for $557 mln

* Cardinal Health put business up for sale due to rule changes

15 Nov 2017

Shanghai Pharma buys U.S. Cardinal Health's China business for $557 million

State-owned Shanghai Pharmaceuticals Holding Co has agreed to acquire Cardinal Health Inc's China drug distribution business for $557 million (423.93 million pounds), as it seeks to expand its distribution and retail network nationwide.

15 Nov 2017

Shanghai Pharma buys U.S. Cardinal Health's China business for $557 mln

Nov 15 State-owned Shanghai Pharmaceuticals Holding Co has agreed to acquire Cardinal Health Inc's China business, one of the nation's largest drug distributors, for $557 million.

15 Nov 2017

BRIEF-Cardinal Health to sell its china business to Shanghai Pharma for $1.2 bln‍​

* Cardinal health signs definitive agreement to sell its china business to Shanghai Pharma

15 Nov 2017

BRIEF-Shanghai Pharmaceuticals' unit‍ signs deal to acquire Cardinal in Malaysia

* Says its unit‍ Century Global signs deal to acquire Cardinal Malaysia for about $557 million

15 Nov 2017

Earnings vs. Estimates